Marca Figurativa depositada no INPI em 01/12/2020 por CytoDyn Inc., processo nº 501581334, nas classes 05, 42, 44. Registro em vigor até 01/12/2030.
| Número do processo | 501581334 |
|---|---|
| Situação | Registro de marca em vigor (Madri) |
| Apresentação | Figurativa |
| Natureza | Madri Produto/Serviço |
| Data do depósito | 01/12/2020 |
| Data da concessão | 26/04/2022 |
| Vigência até | 01/12/2030 |
| Titular | CytoDyn Inc. |
| CNPJ/CPF do titular | — |
| UF · País | — · US |
Therapeutic preparations, namely, therapeutic preparations for the treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19, and therapeutic preparations for the prevention of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; therapeutic preparations, namely, antibodies for use in targeting the CCR5 cell receptor.;
Scientific research consulting services, namely, scientific research consulting services in the field of immunology, and scientific research consulting services in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; medical research services, and medical research services in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; medical research services in the field of antibodies for use in targeting the CCR5 cell receptor.;
Providing health and medical information, and providing health and medical information in the nature of providing information in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19, via a website; providing health and medical information, via a website; providing information in the field of antibodies for use in targeting the C-C chemokine receptor type 5 cell receptor, via a website; medical analysis services, namely, medical analysis services in the field of antibodies for use in targeting the CCR5 cell receptor, and medical analysis services in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19.;
Receba um e-mail a cada novo despacho publicado na RPI para o processo 501581334 — exigência, oposição, deferimento, prazo de pagamento — e quando alguém depositar uma marca parecida.
Monitorar esta marca Ver marcas parecidas3 despacho(s) publicado(s) na Revista da Propriedade Industrial.
1.13.1 Esferas armilares, planetários, órbitas astronômicas, modelos atômicos, modelos moleculares2.9.25 Outras partes do corpo humano